Announcements Trials
Browse Landscape

Phase

Phase NA 42Phase 2 2Phase 4 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 217Fluorouracil 141Oxaliplatin 131Capecitabine 122pembrolizumab 113Irinotecan 109Leucovorin 103Bevacizumab 98Nivolumab 80130-nm albumin-bound paclitaxel 80Cisplatin 79Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 49Carboplatin 47Magnetic Resonance Spectroscopy 43Specimen Handling 39Docetaxel 37Taxes 36Radiation 34fludarabine 33Ipilimumab 33Erlotinib Hydrochloride 33durvalumab 32Biopsy 32Folfox protocol 28Radiosurgery 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Methods × Gastrointestinal × Clear all
NCT01219192 2010-10-28

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen Ltd

Phase 1 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡